Orchid Pharma Ltd
ORCHPHARMAOrchid Pharma Ltd
ORCHPHARMA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 29.93 | 4.17 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Orchid Pharma Limited, formerly Orchid Chemicals & Pharmaceuticals Limited, is a pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bulk actives, formulations and nutraceuticals.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,831.06 | 898.35 | 823.83 | 703.29 | 817.84 | 508.08 | 465.27 | 627.03 | 724.54 | 811.45 | ||||||||||
Raw Materials | 841.34 | 407.53 | 373.85 | 342.63 | 263.14 | 221.68 | 245.60 | 340.62 | 406.10 | 659.31 | ||||||||||
| Power & Fuel Cost | 102.19 | 55.28 | 54.33 | 50.69 | 48.76 | 47.44 | 39.31 | 52.74 | 61.26 | |||||||||||
| Employee Cost | 193.82 | 86.81 | 79.41 | 86.22 | 82.28 | 74.86 | 67.11 | 63.28 | 65.35 | |||||||||||
| Selling & Administrative Expenses | 176.65 | 90.77 | 104.80 | 81.40 | 55.19 | 63.82 | 36.63 | 41.92 | 34.96 | |||||||||||
| Operating & Other expenses | 43.94 | 114.80 | 267.39 | 97.74 | 162.43 | 107.19 | 32.04 | 6.42 | 20.71 | |||||||||||
EBITDA | 473.12 | 143.16 | -55.95 | 44.61 | 206.04 | -6.91 | 44.58 | 122.05 | 136.16 | 152.14 | ||||||||||
| Depreciation/Amortization | 324.58 | 145.27 | 141.05 | 133.31 | 129.94 | 117.93 | 108.92 | 87.02 | 54.79 | 30.94 | ||||||||||
| PBIT | 148.54 | -2.11 | -197.00 | -88.70 | 76.10 | -124.84 | -64.34 | 35.03 | 81.37 | 121.20 | ||||||||||
| Interest & Other Items | 537.12 | 294.24 | 346.77 | 310.26 | 6.69 | 6.23 | 52.21 | 33.46 | 32.90 | 24.51 | ||||||||||
| PBT | -388.58 | -296.35 | -543.77 | -398.96 | 69.41 | -131.07 | -116.55 | 1.57 | 48.47 | 96.69 | ||||||||||
| Taxes & Other Items | -191.94 | -17.25 | -48.34 | -46.19 | 0.00 | 0.00 | 0.00 | 3.52 | 2.15 | 0.75 | ||||||||||
| Net Income | -196.64 | -279.10 | -495.43 | -352.77 | 69.41 | -131.07 | -116.55 | -1.95 | 46.32 | 95.94 | ||||||||||
| EPS | -25.26 | -32.04 | -55.69 | -39.65 | 7.80 | -20.20 | -28.55 | -0.48 | 11.35 | 23.51 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Orchid Pharma Ltd | 61.99 | 4.17 | — |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare ORCHPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 17.57%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Orchid Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.5826% | Percentage of the fund’s portfolio invested in the stock 0.78% | Change in the portfolio weight of the stock over the last 3 months 0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 81/125 (-5) |
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7682% | Percentage of the fund’s portfolio invested in the stock 0.92% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/34 (0) |
Quant Value Fund - Direct Plan Growth Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1457% | Percentage of the fund’s portfolio invested in the stock 4.29% | Change in the portfolio weight of the stock over the last 3 months -0.51% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/44 (-1) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ORCHPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Orchid Pharma - Opening Up Multiple Growth Avenues: Systematix
3 weeks ago•Bloomberg Quint
Orchid Pharma Consolidated June 2023 Net Sales at Rs 182.92 crore, up 39.65% Y-o-Y
3 months ago•Moneycontrol
Orchid Pharma meets SEBI’s minimum public shareholding norms
4 months ago•The Hindu Businessline
Orchid Pharma seeks shareholder nod for Otsuka Chemicals
4 months ago•The Hindu Businessline
Orchid Pharma shares hit fresh high after signing tech transfer pact for cephalosporin intermediate
4 months ago•The Hindu Businessline
Orchid Pharma inks tech transfer pact with biotechnology firm for 7ACA project
4 months ago•The Hindu Businessline
Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
4 months ago•Economic Times
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 0.6%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.35% to 0.23%